Concord Biotech Limited (NSE:CONCORDBIO)
India · Delayed Price · Currency is INR 1,369.80
-0.40 (-0.03%)
At close: Dec 12, 2025
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 143.3 billion as of December 12, 2025. Its market cap has decreased by -33.91% in one year.
Market Cap
143.30B
Enterprise Value
140.00B
Revenue
11.25B
Ranking
n/a
PE Ratio
44.35
Stock Price
1,369.80
Market Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 143.30B, an increase of 45.29%. That is a compound annual growth rate of 17.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 143.30B | -38.04% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
| Aug 18, 2023 | 98.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.30T |
| Divi's Laboratories | 1.71T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.02T |
| Zydus Lifesciences | 934.94B |
| Mankind Pharma | 899.42B |
| Aurobindo Pharma | 694.12B |
| Alkem Laboratories | 673.27B |